| Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ... New England Journal of Medicine 337 (11), 734-739, 1997 | 2483 | 1997 |
| In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors JH Condra, WA Schleif, OM Blahy, LJ Gabryelski, DJ Graham, J Quintero, ... Nature 374 (6522), 569-571, 1995 | 1234 | 1995 |
| Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor JH Condra, DJ Holder, WA Schleif, OM Blahy, RM Danovich, ... Journal of virology 70 (12), 8270-8276, 1996 | 484 | 1996 |
| Prevalence and predictive value of intermittent viremia with combination HIV therapy DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ... Jama 286 (2), 171-179, 2001 | 482 | 2001 |
| Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys J Fan, X Liang, MS Horton, HC Perry, MP Citron, GJ Heidecker, TM Fu, ... Vaccine 22 (23-24), 2993-3003, 2004 | 448 | 2004 |
| Evidence for the direct involvement of the rhinovirus canyon in receptor binding. RJ Colonno, JH Condra, S Mizutani, PL Callahan, ME Davies, MA Murcko Proceedings of the National Academy of Sciences 85 (15), 5449-5453, 1988 | 319 | 1988 |
| 5-Chloro-3-(phenylsulfonyl) indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase TM Williams, TM Ciccarone, SC MacTough, CS Rooney, SK Balani, ... Journal of medicinal chemistry 36 (9), 1291-1294, 1993 | 305 | 1993 |
| Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ... Jama 280 (1), 35-41, 1998 | 285 | 1998 |
| Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. MG Cordingley, RL LaFemina, PL Callahan, JH Condra, VV Sardana, ... Proceedings of the National Academy of Sciences 87 (22), 8985-8989, 1990 | 284 | 1990 |
| 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine RM Gulick, JW Mellors, D Havlir, JJ Eron, A Meibohm, JH Condra, ... Annals of internal medicine 133 (1), 35-39, 2000 | 267 | 2000 |
| Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein J Sprague, JH Condra, H Arnheiter, RA Lazzarini Journal of Virology 45 (2), 773-781, 1983 | 194 | 1983 |
| Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy JH Condra, CJ Petropoulos, R Ziermann, WA Schleif, M Shivaprakash, ... The Journal of infectious diseases 182 (3), 758-765, 2000 | 186 | 2000 |
| A PCSK9-binding antibody that structurally mimics the EGF (A) domain of LDL-receptor reduces LDL cholesterol in vivo 1 [S] YG Ni, S Di Marco, JH Condra, LB Peterson, W Wang, F Wang, S Pandit, ... Journal of lipid research 52 (1), 78-86, 2011 | 177 | 2011 |
| Clinically effective HIV-1 protease inhibitors JP Vacca, JH Condra Drug Discovery Today 2 (7), 261-272, 1997 | 172 | 1997 |
| Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors. RA Zivin, JH Condra, RA Dixon, NG Seidah, M Chretien, M Nemer, ... Proceedings of the National Academy of Sciences 81 (20), 6325-6329, 1984 | 169 | 1984 |
| Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus LD Schultz, J Tanner, KJ Hofmann, EA Emini, JH Condra, RE Jones, ... Gene 54 (1), 113-123, 1987 | 159 | 1987 |
| Gene structure of human cardiac hormone precursor, pronatriodilatin M Nemer, M Chamberland, D Sirois, S Argentin, J Drouin, RAF Dixon, ... Nature 312 (5995), 654-656, 1984 | 156 | 1984 |
| A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density … YG Ni, JH Condra, L Orsatti, X Shen, S Di Marco, S Pandit, MJ Bottomley, ... Journal of Biological Chemistry 285 (17), 12882-12891, 2010 | 145 | 2010 |
| Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors. VV Sardana, EA Emini, L Gotlib, DJ Graham, DW Lineberger, WJ Long, ... Journal of Biological Chemistry 267 (25), 17526-17530, 1992 | 137 | 1992 |
| Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors VW Byrnes, VV Sardana, WA Schleif, JH Condra, JA Waterbury, ... Antimicrobial agents and chemotherapy 37 (8), 1576-1579, 1993 | 135 | 1993 |
